On November 20, 2023, Leap Therapeutics Inc (NASDAQ: LPTX) opened at $1.85, higher 13.11% from the last session. During the day, the shares moved up to $2.2412 and dropped to $1.80 before settling in for the closing price of $1.83. Price fluctuations for LPTX have ranged from $1.24 to $10.20 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -20.00% over the past five years. Company’s average yearly earnings per share was noted 24.88% at the time writing. With a float of $23.46 million, this company’s outstanding shares have now reached $25.57 million.
Let’s look at the performance matrix of the company that is accounted for 44 employees.
Leap Therapeutics Inc (LPTX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Leap Therapeutics Inc is 8.22%, while institutional ownership is 27.78%.
Leap Therapeutics Inc (LPTX) Performance Highlights and Predictions
This company achieved a return on equity of -65.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.49% during the next five years compared to 31.98% growth over the previous five years of trading.
Leap Therapeutics Inc (NASDAQ: LPTX) Trading Performance Indicators
Check out the current performance indicators for Leap Therapeutics Inc (LPTX). In the past quarter, the stock posted a quick ratio of 7.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.72, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -2.20 in one year’s time.
Technical Analysis of Leap Therapeutics Inc (LPTX)
Leap Therapeutics Inc (NASDAQ: LPTX) saw its 5-day average volume 0.27 million, a positive change from its year-to-date volume of 0.18 million. As of the previous 9 days, the stock’s Stochastic %D was 74.12%. Additionally, its Average True Range was 0.21.
During the past 100 days, Leap Therapeutics Inc’s (LPTX) raw stochastic average was set at 33.20%, which indicates a significant decrease from 81.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.03% in the past 14 days, which was higher than the 93.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5200, while its 200-day Moving Average is $3.5300. Nevertheless, the first resistance level for the watch stands at $2.2700 in the near term. At $2.4800, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.7200. If the price goes on to break the first support level at $1.8300, it is likely to go to the next support level at $1.6000. Assuming the price breaks the second support level, the third support level stands at $1.3900.
Leap Therapeutics Inc (NASDAQ: LPTX) Key Stats
There are currently 25,565K shares outstanding in the company with a market cap of 52.93 million. Presently, the company’s annual sales total 0 K according to its annual income of -54,600 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -13,390 K.